Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WONGENY, formally Suzhou Wanguiyuan Precision Technology, is a China-based precision manufacturing and CDMO company serving in vitro diagnostics, medical devices, life science, and biopharma customers. The company focuses on microfluidic chips, high-value bio-consumables, life science instruments, automation equipment, mold design, process development, and scaled production services. Its offering appears to be service- and platform-oriented rather than drug-development oriented, with capabilities spanning OEM, ODM, CMO, and CDMO projects. WONGENY highlights fully automated microfluidic chip production and integrated solutions combining automation, consumables, and instrumentation. The business is best characterized as a commercial-stage healthcare tools and advanced manufacturing supplier rather than a therapeutics biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WONGENY.